Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 10, 2014 09:51 ET | Source: Provista Diagnostics, Inc.

Provista Diagnostics Accepted for a Late-Breaking Data Presentation at the 2014 San Antonio Breast Cancer Symposium

NEW YORK, Nov. 10, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately-held molecular diagnostics company focused on developing and commercializing a new generation of proprietary...
September 09, 2014 08:54 ET | Source: Provista Diagnostics, Inc.

Provista Diagnostics to Present at Rodman & Renshaw Annual Global Investment Conference

NEW YORK, Sept. 9, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately-held molecular diagnostics company focused on developing and commercializing proprietary blood-based diagnostic,...
September 08, 2014 13:42 ET | Source: Provista Diagnostics, Inc.

Provista Diagnostics Announces Key Data Presented at the American Society of Clinical Oncologist Breast 2014 Annual Meeting

NEW YORK, Sept. 8, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately-held molecular diagnostics company focused on developing and commercializing proprietary blood-based diagnostic,...
July 15, 2014 05:00 ET | Source: Provista Diagnostics, Inc.

Provista Diagnostics Completes Enrollment of its 001 Prospective Study of Protein-Based Biomarker Blood Test to Aid in Detection of Breast Cancer

New York, NY, July 15, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a personalized medicine company focused on developing and commercializing proprietary blood-based prognostic, diagnostic,...
July 07, 2014 05:00 ET | Source: Provista Diagnostics, Inc.

Provista Diagnostics, Inc. Appoints Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer

New York, NY, July 7, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a molecular diagnostics company developing and commercializing proteomic-based diagnostic, prognostic and monitoring tests...
June 26, 2014 05:00 ET | Source: Provista Diagnostics, Inc.

Provista Diagnostics Laboratory Receives Accreditation from College of American Pathologists (CAP)

New York, NY, June 26, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a molecular diagnostics company delivering precision medicine to the medical community to fundamentally change the detection...
May 28, 2014 05:00 ET | Source: Provista Diagnostics, Inc.

Provista Diagnostics Expands Exclusive License Agreement for Biomarker Technologies Developed at the Biodesign Institute at Arizona State University

NEW YORK, NY, May 28, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a molecular diagnostics company developing and commercializing proteomic-based diagnostic, prognostic and monitoring tests...
May 19, 2014 05:00 ET | Source: Provista Diagnostics, Inc.

Provista Diagnostics Announces First Patient Enrolled in Prospective, Proof-of-Concept Study of its Protein Biomarker Blood Test to Assess the Presence of Breast Cancer

New York, NY, May 19, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a molecular diagnostics company developing and commercializing proteomic-based diagnostic, prognostic and monitoring tests...
April 16, 2014 05:00 ET | Source: Provista Diagnostics, Inc.

Provista Diagnostics Secures $6MM Series B Financing

Scottsdale, Arizona, April 16, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately held molecular diagnostics company developing and commercializing diagnostic, prognostic and predictive...
October 25, 2013 05:00 ET | Source: Provista Diagnostics, Inc.

Provista Diagnostics Licenses Biomarker Technologies Developed at Arizona State University

Scottsdale, Arizona, Oct. 25, 2013 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a leading molecular diagnostics company focused on developing and commercializing proprietary diagnostic, prognostic...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right